Filing Details
- Accession Number:
- 0001493152-22-026629
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-23 10:58:22
- Reporting Period:
- 2022-09-22
- Accepted Time:
- 2022-09-23 10:58:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1710340 | Eton Pharmaceuticals Inc. | ETON | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1669976 | Sean Brynjelsen | C/O Eton Pharmaceuticals, Inc. 21925 W Field Pkwy,Suite 235 Deer Park IL 60010-7208 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-22 | 10,000 | $2.10 | 1,040,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 24,940 | Indirect | By LLC |
Billionaire Hedge Funds
